The mechanism that initiates human parturition has been proposed to be 
Introduction
Progesterone receptors are members of a superfamily of ligand-activated nuclear transcription factors comprised of specific domains involved in DNA binding, hormone binding, and transactivation (1) . Progesterone activation of PR in target tissues is mediated via dimerisation and phosphorylation of the receptor, resulting in binding to 5 cis-acting progesterone response elements on DNA and the modulation of the promoters of target genes (1, 2). The human PR-A isoform differs from the PR-B isoform in lacking the first 164 amino acids contained in PR-B (3). Both are translated from distinct mRNA transcripts generated from a single gene under the control of separate oestrogen sensitive promoters (4) . Previous work has identified three additional AUG 10 translation sites with a possible methionine site at 595 that is predicted to generate a protein of approximately 60 kDa (5) .
Although much work has been performed on PR-B and PR-A, little work has been undertaken on the other 7 transcripts generated from the PR gene (5), despite there being evidence that some of these are translated into functional 38 kDa, 60kDa, 71kDa 15 or 78kDa proteins in malignant progesterone target tissues (6) and that these are coordinately up-regulated by oestrogens and down-regulated by progestins (7, 8) .
Evidence also exists for other PR isoform such as PR-C, PR-S and PR-T, which could be genomic mediators of progestin action (9, 10) and for three membrane progestin receptors that are classical G-coupled protein receptor-transduction molecules first 20 identified in the teleost oocyte called mPRα, mPRβ and mPRγ (11, 12) .
Progesterone receptors have been proposed to play a key role in the control of human labour and parturition whereby the levels of the PR-B isoform, which is often considered to be the dominant isoform, fall during labour leaving the PR-A isoform as the predominant form leading to a 'functional progesterone receptor withdrawal' (13) . 25
Evidence to support this occurring in the uterine myometrium exists (14) . In other human reproductive tissues, such as the decidua, ovary and the oviduct (15, 16), PR-A appears to be the predominant progestin regulator with PR-B maintaining a supporting role suggesting that progestin signalling in the human uterus at the end of parturition is far more complex than a PR-B to PR-A isoform switching mechanism (14) . Despite 30 there being a paucity of data to support 'functional progesterone receptor withdrawal' in tissues at the fetal-maternal interface, i.e. in the fetal membranes, decidua and placenta, many still consider that only the PR-B and PR-A isoforms are present (17, 18).
Recent data has suggested that at least five nuclear PR-isoforms are present in the human decidua and that all five isoforms are decreased after labour (19). However, 35 although western blotting techniques also indicated the presence of several PR isoforms in amniotic nuclear extracts, immunohistochemical methods failed to detect any PR isoforms in the amnion and chorion (19).
In the present study examining the pattern of expression of PR isoforms in human fetal membranes (amnion and chorion), decidua and placenta at term, we demonstrate 40 that the major isoform present in the fetal membranes and placenta is a cytoplasmic 60-kDa PR-C isoform, that PR-B or PR-A is not expressed in the amnion or chorion, and the 94kDa PR-A protein is the dominant PR isoform in the decidua
Materials and Methods

Patient Samples. 45
Local Research Ethics Committee approval for the study was obtained and all patients signed informed consent for their tissues to be used. Fetal membranes and placenta (n=6) were collected from term patients undergoing elective Caesarean section prior to labour. All tissues were divided into 3 parts; one fixed in formalin and embedded in paraffin for histological examination, the other two snap-frozen in liquid nitrogen and 50 stored at -80°C for later RNA and protein extraction. Enriched amnion was obtained carefully peeling of the amnion from chorion and decidua. Enriched decidua was obtained using the edge of a microscope slide to carefully remove a thin layer form the inverted fetal membranes. Enriched chorion was obtained by using the edge of the microscope slide to scrape away the remaining decidua. A 2cm 3 block of placenta from 55 the mid-part of a cotyledon was taken and washed briefly with sterile PBS before division into 3 parts.
Immunohistochemistry.
Five µm sections of tissue dried for 48 hr prior to de-waxing and re-hydration through graded alcohol to H 2 O were subjected to boiling 10mM citric acid for 12min followed 60 by cooling for exactly 20min before transfer into cold H 2 O to retrieve antigenic sites.
Endogenous peroxidase activity and specific binding was blocked with 6% H 2 O 2 for 15 min, followed by incubation with non-immune rabbit serum (10% in PBS) for 30 min, respectively. Endogenous avidin and biotin sites were blocked with Avidin-Binding blocking solutions (Vector Laboratories, Peterborough, UK) according to the 65 manufacturer's instructions. Primary antibody, PR clones 1A6, San27, clone 16, or the polyclonal antibody C-20 (Santa Cruz SC-539) were applied at the indicated concentrations (Fig 1) in 10% non-immune rabbit serum or 10% swine serum overnight at 4°C. In some studies, C-20 antibodies were pre-incubated (3 hr at room temperature) with a 7-fold excess of immunising peptide before use. After copious washing in PBS, 70 biotinylated rabbit anti-mouse or swine anti-rabbit secondary antibodies (1:400) were applied for 1hr 30 min, the sections washed and avidin-biotin complexes applied for 30 min. Colour was developed over antigenic sites using 3, 3'-diaminobenzidine for 5 min.
After copious washes in dH 2 O, sections were lightly counterstained with haematoxylin, dehydrated through graded alcohols, cleared in xylene and permanently mounted in 75 XAM (BDH, Poole, UK). Photomicrographs were obtained at the indicated magnifications on a Zeiss Axioplan compound microscope fitted with a Nikon DN-100 digital camera. Images were digitally enhanced using proprietary software.
RNA preparation and RT-PCR.
Total cellular RNA was obtained from 100mg of tissue using Trizol reagent (Invitrogen, 80
Paisley, UK) according the manufacturer's instructions, and genomic DNA contamination removed by treating the samples with RNase-free DNase 1 (Promega, Southampton, UK) for 1 hour at 37°C, followed by phenol-chloroform extraction and isopropanol precipitation. After verification of RNA quality by UV-spectrophotometer analysis and agarose gel electrophoresis, one µg of RNA was reverse transcribed using 85 AMV-RT for one hr at 42°C. A minus RT control was obtained by substituting DEPCtreated water for the AMV-RT enzyme.
PCR was performed using PR primer combinations that identified all PR isoforms, the PR-B isoform, the PR-A and PR-B isoforms or the PR-S isoform (20); (Table 1) .
Western Blotting. 90
Protein extracts were obtained by homogenising samples in ice-cold lysis buffer (1% Ipegcal, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 2mM EDTA, 50mM sodium fluoride, 1 mM sodium metavanadate, 0.2 mg/ml aprotinin all (Fig 1c) .
However, cytoplasmic and nuclear immunoreactivity was observed in decidual cells attached to the basal plate (Fig 1c) . 120
To confirm the identity of the cytoplasmic isoform found in these cell types, immunostaining with PR-B-and PR-A-specific antibodies revealed nuclear staining in the decidual cell, but no other staining elsewhere in the fetal membrane (Fig 1) .
Similarly, nuclear staining was confined only to the decidual cells of the basal plate attached to the placenta (Fig 1e) . Nuclear staining in classical progesterone target 125 tissues (breast cancer, endometrial, and myometrial cells) confirmed the PR-B and PR-A specificity of the antibodies (data not shown). The conclusion from these studies was that the cytoplasmic isoform found within fetal membranes, decidua and the syncytiotrophoblast of the placenta was neither the PR-B nor the PR-A isoform and suggestive of one of the other PR isoforms. These data were inconsistent with previous 130 observations that the amnion epithelial cell contained both PR-B and PR-A isoforms and that during labour there is a loss of the PR-B isoform in favour of the PR-A isoform (17), but is consistent with immunohistochemical studies of Goldman et al. (19) .
To find the identity of the cytoplasmic progesterone receptor isoform, RNA extracts prepared from term fetal membrane and placenta samples were subjected to 135
RT-PCR with several isoform-specific primer sets (Table 1 ) and revealed the presence of a PR transcript in all samples by RT-PCR (Fig 2a & 2b; top panels). Analysis with PR-B-, PR-A/PR-B-and PR-S-specific primer sets showed that fetal membranes with decidua attached consisted mainly of PR-A transcripts with some transcripts for PR-B, but no PR-S transcripts (Fig 2) . Fetal membranes enriched for amniochorion revealed 140 the presence of a transcript for PR that was not PR-B, not PR-A or PR-S leading to conclusion that the cytoplasmic PR isoform present was either PR-C or PR-M previously observed in human breast cancer cells and isolated from human aortic endothelial cells, respectively (6, 9, 23). The placenta similarly contained a transcript for PR that was either PR-C, or PR-M (Fig 2b) . Samples enriched for decidua revealed 145 the presence of all PR isoforms including PR-S (Fig 2b) .
When protein extracts from partially purified fetal membranes, placenta, trophoblasts and decidua were compared with those from T47D breast cancer cells, using western blotting techniques with the PR antibodies that detected the cytoplasmic isoform in the immunohistochemistry studies (Fig 1; Table 2 ), several PR 150 immunoreactive proteins were observed in T47D breast cancer cell extracts in line with previous studies (8, 19, 21) , whereas the tissues at the fetal maternal interface revealed a major PR isoform with a relative molecular mass of ~60 kDa (Fig 3) . This isoform was confirmed as the PR-C isoform, as previously reported in human breast cancer cells (5, 23), human fetal membranes (19) and the guinea pig cervix (21), with recombinant 155 protein and pre-adsorption studies (Fig 3) . Other progesterone target tissues, such as endometrium (data not shown) and myometrium possessed the 116 kDa PR-B, 94 kDa PR-A and 60 kDa PR-C isoforms but only with the C-20 antibody (Fig 3) .
Discussion
The role of progesterone receptors in human gestation and parturition is to maintain 160 pregnancy. In most mammals, the stability of the relationship in the fetal-maternal interface is disturbed by the fall of progesterone production by the placenta, with the concomitant softening of the cervix, rupture of the fetal membranes and initiation of highly synchronised high pressure contractions of the myometrium that characterises labour (24). In the human, similar events occur in the same coordinated manner except 165 there is no loss of systemic progesterone (24). A hypothesis presented (17), that a 'switch' in PR isoforms from the more transcriptionally dominant PR-B to the less active PR-A isoform must therefore occur in these tissues, has been convincingly supported by evidence in the myometrium (25, 26), and in the cervix (27, 28) and less convincingly in the amnion and maternal decidua (19) . 170
In the present study we have shown that the fetal membranes (amnion epithelial cell and chorionic cytotrophoblast) contain mainly high levels of PR-C (Fig 1; Table 2 ), whereas the placental cytotrophoblast is devoid of PR and the placental syncytiotrophoblast contains both PR-C and PR-A (Table 2) . By contrast, the maternal decidua contains not only PR-A, as its major isoform, but also PR-B, PR-S and the 175 cytoplasmic PR-C. These data differ from those recently reported (19) where PR-B and PR-A isoforms were observed in amnion nuclear extracts yet, paradoxically, the antibody used failed to show immunoreactive PR by immunohistochemistry and theoretically, should not detect the PR-C, PR-S, or PR-M isoforms in western blotting, as the epitope for this antibody is found only at the N-terminal region of the PR-A 180 isoform (29). In the present study, no PR-B or PR-A isoforms were detected in the amnion or chorion and the hypothesis that progesterone receptor switching occurs within these tissues at term or in labour (17) is not supported. Although, we cannot rule out the presence of a small amount of PR-B or PR-A isoforms being present in the nuclei of amnion epithelial cells, despite a lack of expression of these isoforms at the 185 mRNA level (Fig 2) , the present study indicates that PR-B and PR-A are of little importance in relation to PR-C in fetal membranes. Additionally, the PR immunoreactivity in the present study that we consider represents the C isoform, was confined to the cytoplasm of the amniotic epithelium and the chorionic cytotrophoblast, and was the major isoform present, whereas no cytoplasmic immunoreactivity was 190 detected in the aforementioned study (19). These data are qualitatively similar to that obtained in the baboon (30), where PR was not observed in the amnion or chorion, but strong nuclear and weak cytoplasmic staining was observed in the decidua with the JZB39 rat anti-PR monoclonal antibody. Observations obtained with JZB39 (31), which has been shown to only detect the PR-C isoform in myometrium and not T47D extracts 195 by immunoblotting, were dependent upon protein concentrations (31). These data suggest that protein loading in immunoblotting is critical for good PR-C detection.
Indeed, PR-C was weakly represented on western blotting in a previous study (19), whereas our data show intense PR-C expression (Fig 3) for this exact reason.
Alternatively, these discrepant observations may be related to the antibodies used, the 200 use of nuclear extracts compared to whole cell extracts or the presence of contaminating cytoplasm/tissues in the previous study (19).
In agreement with our studies, Goldman et al. (19) showed that PR-A is expressed in the nucleus of the decidua but absent in the amnion by immunohistochemistry, but paradoxically, found all isoforms present by western blotting. By contrast, our western 205 blot studies indicate the major PR isoform in the fetal membranes (amnion and chorion) is C and that it is localised within the cytoplasm, without immunoreactivity within the nuclei of the same cells and, therefore, we consider that the relevance of the changes in levels of the PR isoforms detected within the amniotic nuclear extracts of labour (19), should be considered with caution. 210
Using antibodies that detect all known PR isoforms, we demonstrated that the major isoform in the amnion, chorion and syncytiotrophoblast is the 60kDa PR-C isoform (Fig 3) . The absence of PR-B and PR-A transcripts in these tissues (Fig 2) confirmed these findings. By contrast, the major isoform in the term decidua is PR-A, but PR-B, PR-S and PR-C isoforms are also expressed. In light of the study by Goldman 215 et al., these data need further clarification, but suggest that PR-C is an important molecule in the fetal membranes, decidua and syncytiotrophoblast. These data also suggest that a re-evaluation of the roles of PR in the fetal-maternal interface is needed and the idea that PR-A simply acts as a dominant negative regulator of PR-B action is not applicable to these tissues (17). 220
The mechanism involved in the synthesis of the PR-C isoform is unknown, but limited evidence suggests that it may be produced using a third oestrogen dependent promoter with an AUG at amino acid 595 being the translational start site (5). The demonstration that PR-C isoforms in the human breast cancer cell do not arise from proteolysis of larger PR-isoforms (9) and that specific PR-C mRNA transcripts are 225 present in human fetal membranes and placenta (this study), strongly suggests that the PR-C isoform is generated through promoter specific transcription. The function of PR-C is unclear, although it may act as modulator of PR-A and PR-B transcriptional activities in those cells that produce these isoforms (9) . In the human amnion and chorion, dominant negative regulation of PR-B and PR-A transcriptional control seems 230 unlikely in the absence of any measurable PR-A or PR-B isoforms and point towards PR-C specific functions. Since PR-C lacks a full DNA binding domain (9) , but has a nuclear localisation signal and two dimerisation domains, the intriguing possibility that PR-C may associate with other transcriptional elements to modulate gene transcription is raised. However, the cytoplasmic location and relatively high levels of this protein are 235
suggestive of a localised function in the cytoplasm rather than a nuclear genomic function and that this localisation is important for sustained gestation. It now seems imperative that the regulation and role of the PR-C isoform is investigated to further our understanding of the role of progesterone in these tissues during human parturition.
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Conneely were then amplified in a PCR with isoform-specific primers (see Figure 1 ; Table 1 
